Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (401)	1/29/2003 4:04:10 PM
From: scaram(o)uche	Read Replies (1) of 598

Goeddel, running alone down the path that he couldn't sell to investors, 607/67. Sigh. Hurts. One gets burned, running into "distribution". But, if he hadn't made such a critical error, the opportunity of TLRK wouldn't be offered up at a research premium of $100M. You're ticked about communications with scientists. I'm ticked at the continuous flow of hedge fund managers who know, beforehand, about biotech "distributions" and forward sales agreements. >> That is, the company owes it to those who will stick with it through the next 18 months to keep tight lips << For some time, Goeddel has been adamant that the company had good partnership discussions, that there was only upside to be gained from patience. His shareholders who bought into this quiet confidence or not-overt arrogance? We have 100% of the paper but (arbitrary, based on my pain to date) 25% of the value.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next